Lupus: Open Access
Open Access

Substantial Evidence of a Genetic Predisposition to Lupus Hereditary

Joe Clark^{* *}Correspondence: Joe Clark, Department of Medicine and Health Science, University of Cambridge, Cambridge, United Kingdom, Email:

Author info »

Description

Lupus, or Systemic Lupus Erythematosus (SLE), is a complex autoimmune disease that affects millions of individuals worldwide. It is characterized by a dysregulated immune system attacking healthy tissues and organs, leading to chronic inflammation and various clinical manifestations. While the exact cause of lupus remains unknown, extensive research has shed light on the role of genetic factors in its development. This study explores the hereditary aspects of lupus and delves into the genetic components that contribute to its susceptibility. Genetic Basis of Lupus Genetic studies have provided substantial evidence of a genetic predisposition to lupus. Numerous investigations, including twin and family studies, have demonstrated a higher concordance rate among monozygotic twins compared to dizygotic twins, supporting the idea of a genetic component. The risk of developing lupus is also higher in first-degree relatives of affected individuals, further indicating a hereditary basis.

Human Leukocyte Antigen (HLA) genes have been extensively studied in relation to lupus. These genes encode proteins involved in immune system regulation and antigen presentation. Variations in certain HLA genes, particularly HLA-DR and HLADQ alleles, have been strongly associated with lupus susceptibility. These variations may affect immune responses and contribute to the breakdown of self-tolerance. Non-HLA genes have also been implicated in lupus development. Multiple genes involved in immune system pathways, such as interferon signaling, B-cell function, and immune complex clearance, have shown associations with the disease. Examples include IRF5, STAT4, BLK, and BANK1 among others. These genetic variations can influence immune cell activation, cytokine production, and immune complex handling, ultimately contributing to lupus pathogenesis. In addition to genetic variations, epigenetic modifications play a role in regulating gene expression and can influence lupus susceptibility. Epigenetics refers to changes in gene activity that are not caused by alterations in the DNA sequence itself but rather through modifications to DNA and associated proteins. DNA methylation, histone modifications, and microRNAs are among the key epigenetic mechanisms involved in lupus. Aberrant DNA methylation patterns have been observed in lupus patients, affecting the expression of genes involved in immune regulation. Hypermethylation of specific genes, such as FOXP3 and CD70, has been associated with lupus development. Histone modifications, including acetylation and methylation, also contribute to the dysregulation of immune response genes.

MicroRNAs (miRNAs) are small non-coding RNA molecules that can post-transcriptionally regulate gene expression. Altered miRNA profiles have been identified in lupus patients and are thought to modulate immune responses and contribute to disease progression. Certain miRNAs, such as miR-21 and miR-155, have been found to be upregulated in lupus and can promote inflammation and immune dysregulation. While genetic factors play a significant role in lupus susceptibility, it is important to note that the disease's development is not solely determined by genetics. Gene-environment interactions also contribute to the manifestation of lupus. Environmental factors, such as Ultraviolet (UV) radiation, infections, hormones, and certain medications, can trigger or exacerbate the disease in genetically predisposed individuals. UV radiation is known to induce DNA damage and promote inflammation, potentially triggering lupus flares. Hormonal factors, particularly estrogen, have been implicated in lupus pathogenesis. Estrogen can affect immune cell function and contribute to the breakdown of selftolerance infections.